Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study

Clinical trial NCT01040325 · COMPLETED

Trial details

NCT number: NCT01040325
Sponsor: Intercell USA, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Traveler's Diarrhea

Start date: 2009-12-01
Primary completion: 2010-06-01
Enrollment: 723

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.